Safety and Efficacy of Metabolic Surgery in Patients with Type 2 Diabetes in the Middle East and North Africa Region: An Analysis of Primary Roux-en-Y Gastric Bypass and Sleeve Gastrectomy Outcomes

• Published in: Journal of clinical medicine 2023-08, Vol.12 (15), p.5077
• Main Authors: Fares, Sami, Barajas-Gamboa, Juan S, Díaz Del Gobbo, Gabriel, Klingler, Michael, Pantoja, Juan Pablo, Abril, Carlos, Raza, Javed, Guerron, Alfredo D, Corcelles, Ricard, Allemang, Matthew, Rodriguez, John, Kroh, Matthew
• Format: Article
• Language: English
• Subjects: Abdomen; Body mass index; Clinical medicine; Complications and side effects; Diabetes; Gastrectomy; Gastric bypass; Gastrointestinal surgery; Hyperglycemia; Metabolism; Mortality; Obesity; Patient outcomes; Patients; Postoperative period; Productivity; Public health; Surgical outcomes; Weight control
• ISSN: 2077-0383; 2077-0383
• DOI: 10.3390/jcm12155077

Type 2 diabetes (T2D) is a chronic medical condition that results in significant health implications and reduced life expectancy. The International Diabetes Federation (IDF) estimated that in 2021, 51.8% of all deaths of people under 60 years old in the Middle East and North Africa (MENA) region were related to diabetes. Bariatric surgery has been demonstrated to be a safe and effective treatment for T2D in different populations worldwide, though few specific data exist on outcomes of procedures in the MENA region. The aim of this study was to compare the safety and postoperative outcomes between patients with and without T2D undergoing primary bariatric surgery at a tertiary referral academic medical center in the United Arab Emirates. All patients who underwent primary metabolic surgery between September 2015 and July 2020 were retrospectively reviewed from a prospective database. Group 1 included patients with T2D, and Group 2 included patients without T2D. Patients undergoing revisional or correctional operations were excluded. The procedure performed was based on surgeon discretion in discussion with a multidisciplinary team and the patient. Demographics as well as perioperative and postoperative results were examined. Our study included 542 patients, 160 (29.5%) with T2D and 382 (70.5%) with non-T2D. Mean age was 44.5 years (range 16-70) in the T2D group and 33.3 years (range 15-63) in the non-T2D group; median BMI was 41.8 ± 7.3 and 43.2 ± 7.2, respectively. The T2D group was 37.5% male and 62.5% female, and the non-T2D group was 38.7% male and 61.3% female. There were no significant differences in comorbidities. In the T2D group, 45.6% of patients underwent Roux-en-Y gastric bypass and 54.4% sleeve gastrectomy. In the non-TD2 group, 42.7% of patients received Roux-en-Y gastric bypass and 57.3% sleeve gastrectomy. There were no statistically significant differences in postoperative ED visits (21.8% vs. 24.3%, 0.21), minor complications within 30 days (4.3% vs. 5.2%, 0.67), readmission rates (5.6% vs. 4.9%, 0.77), re-operation rates (3.7% vs. 1.5%, 0.11), median hospital stay (2.0 days vs. 3.0, 0.05), or complications after 30 days (6.2% vs. 11.2%, 0.07). There were no deaths either group. In this cohort of patients from the MENA region, bariatric surgery in T2D patients is safe and effective, with perioperative outcomes comparable to those of non-T2D patients. To the best of our knowledge, our postoperative findings, which are the first report in th